0
     

Report Added
Report already added
Global Vaccine Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Vaccine Market 2021 by Company, Regions, Type and Application, Forecast to 2026

The Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Vaccine size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Vaccine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others

Market segment by Application, can be divided into
For Adult
For Child

Market segment by players, this report covers
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Vaccine
1.2 Classification of Vaccine by Type
1.2.1 Overview: Global Vaccine Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Vaccine Revenue Market Share by Type in 2020
1.2.3 Varicella Vaccine
1.2.4 Influenza Vaccine
1.2.5 Polio Vaccine
1.2.6 Hepatitis A Vaccine
1.2.7 Rabies Vaccine
1.2.8 BCG Vaccine
1.2.9 Hepatitis B
1.2.10 Pertussis, Diphtheria, Tetanus
1.2.11 Pneumococcal
1.2.12 Others
1.3 Global Vaccine Market by Application
1.3.1 Overview: Global Vaccine Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 For Adult
1.3.3 For Child
1.4 Global Vaccine Market Size & Forecast
1.5 Global Vaccine Market Size and Forecast by Region
1.5.1 Global Vaccine Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Vaccine Market Size by Region, (2016-2021)
1.5.3 North America Vaccine Market Size and Prospect (2016-2026)
1.5.4 Europe Vaccine Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Vaccine Market Size and Prospect (2016-2026)
1.5.6 South America Vaccine Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Vaccine Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Vaccine Market Drivers
1.6.2 Vaccine Market Restraints
1.6.3 Vaccine Trends Analysis
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Vaccine Product and Solutions
2.1.4 AstraZeneca Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 BioNTech
2.2.1 BioNTech Details
2.2.2 BioNTech Major Business
2.2.3 BioNTech Vaccine Product and Solutions
2.2.4 BioNTech Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 BioNTech Recent Developments and Future Plans
2.3 Boehringer-Ingelheim
2.3.1 Boehringer-Ingelheim Details
2.3.2 Boehringer-Ingelheim Major Business
2.3.3 Boehringer-Ingelheim Vaccine Product and Solutions
2.3.4 Boehringer-Ingelheim Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Boehringer-Ingelheim Recent Developments and Future Plans
2.4 CCBIO
2.4.1 CCBIO Details
2.4.2 CCBIO Major Business
2.4.3 CCBIO Vaccine Product and Solutions
2.4.4 CCBIO Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 CCBIO Recent Developments and Future Plans
2.5 CSL
2.5.1 CSL Details
2.5.2 CSL Major Business
2.5.3 CSL Vaccine Product and Solutions
2.5.4 CSL Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 CSL Recent Developments and Future Plans
2.6 CureVac
2.6.1 CureVac Details
2.6.2 CureVac Major Business
2.6.3 CureVac Vaccine Product and Solutions
2.6.4 CureVac Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 CureVac Recent Developments and Future Plans
2.7 Elanco
2.7.1 Elanco Details
2.7.2 Elanco Major Business
2.7.3 Elanco Vaccine Product and Solutions
2.7.4 Elanco Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Elanco Recent Developments and Future Plans
2.8 GSK
2.8.1 GSK Details
2.8.2 GSK Major Business
2.8.3 GSK Vaccine Product and Solutions
2.8.4 GSK Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 GSK Recent Developments and Future Plans
2.9 Hulan Bio
2.9.1 Hulan Bio Details
2.9.2 Hulan Bio Major Business
2.9.3 Hulan Bio Vaccine Product and Solutions
2.9.4 Hulan Bio Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Hulan Bio Recent Developments and Future Plans
2.10 Indian Immunologicals
2.10.1 Indian Immunologicals Details
2.10.2 Indian Immunologicals Major Business
2.10.3 Indian Immunologicals Vaccine Product and Solutions
2.10.4 Indian Immunologicals Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Indian Immunologicals Recent Developments and Future Plans
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck Vaccine Product and Solutions
2.11.4 Merck Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Merck Recent Developments and Future Plans
2.12 Minhai Biotechnology
2.12.1 Minhai Biotechnology Details
2.12.2 Minhai Biotechnology Major Business
2.12.3 Minhai Biotechnology Vaccine Product and Solutions
2.12.4 Minhai Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Minhai Biotechnology Recent Developments and Future Plans
2.13 Mitsubishi Tanabe Pharma
2.13.1 Mitsubishi Tanabe Pharma Details
2.13.2 Mitsubishi Tanabe Pharma Major Business
2.13.3 Mitsubishi Tanabe Pharma Vaccine Product and Solutions
2.13.4 Mitsubishi Tanabe Pharma Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Mitsubishi Tanabe Pharma Recent Developments and Future Plans
2.14 Moderna Therapeutics
2.14.1 Moderna Therapeutics Details
2.14.2 Moderna Therapeutics Major Business
2.14.3 Moderna Therapeutics Vaccine Product and Solutions
2.14.4 Moderna Therapeutics Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Moderna Therapeutics Recent Developments and Future Plans
2.15 Mylan
2.15.1 Mylan Details
2.15.2 Mylan Major Business
2.15.3 Mylan Vaccine Product and Solutions
2.15.4 Mylan Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Mylan Recent Developments and Future Plans
2.16 Plumbline Life Sciences
2.16.1 Plumbline Life Sciences Details
2.16.2 Plumbline Life Sciences Major Business
2.16.3 Plumbline Life Sciences Vaccine Product and Solutions
2.16.4 Plumbline Life Sciences Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Plumbline Life Sciences Recent Developments and Future Plans
2.17 Sanofi
2.17.1 Sanofi Details
2.17.2 Sanofi Major Business
2.17.3 Sanofi Vaccine Product and Solutions
2.17.4 Sanofi Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Sanofi Recent Developments and Future Plans
2.18 Translate Bio
2.18.1 Translate Bio Details
2.18.2 Translate Bio Major Business
2.18.3 Translate Bio Vaccine Product and Solutions
2.18.4 Translate Bio Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Translate Bio Recent Developments and Future Plans
2.19 Walvax Biotechnology
2.19.1 Walvax Biotechnology Details
2.19.2 Walvax Biotechnology Major Business
2.19.3 Walvax Biotechnology Vaccine Product and Solutions
2.19.4 Walvax Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Walvax Biotechnology Recent Developments and Future Plans
2.20 Wuhan Institute of Biological Products
2.20.1 Wuhan Institute of Biological Products Details
2.20.2 Wuhan Institute of Biological Products Major Business
2.20.3 Wuhan Institute of Biological Products Vaccine Product and Solutions
2.20.4 Wuhan Institute of Biological Products Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Wuhan Institute of Biological Products Recent Developments and Future Plans
2.21 Zoties
2.21.1 Zoties Details
2.21.2 Zoties Major Business
2.21.3 Zoties Vaccine Product and Solutions
2.21.4 Zoties Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Zoties Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Vaccine Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Vaccine Players Market Share
3.2.2 Top 10 Vaccine Players Market Share
3.2.3 Market Competition Trend
3.3 Vaccine Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Vaccine Revenue and Market Share by Type (2016-2021)
4.2 Global Vaccine Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Vaccine Revenue Market Share by Application (2016-2021)
5.2 Vaccine Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Vaccine Revenue by Type (2016-2026)
6.2 North America Vaccine Revenue by Application (2016-2026)
6.3 North America Vaccine Market Size by Country
6.3.1 North America Vaccine Revenue by Country (2016-2026)
6.3.2 United States Vaccine Market Size and Forecast (2016-2026)
6.3.3 Canada Vaccine Market Size and Forecast (2016-2026)
6.3.4 Mexico Vaccine Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Vaccine Revenue by Type (2016-2026)
7.2 Europe Vaccine Revenue by Application (2016-2026)
7.3 Europe Vaccine Market Size by Country
7.3.1 Europe Vaccine Revenue by Country (2016-2026)
7.3.2 Germany Vaccine Market Size and Forecast (2016-2026)
7.3.3 France Vaccine Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Vaccine Market Size and Forecast (2016-2026)
7.3.5 Russia Vaccine Market Size and Forecast (2016-2026)
7.3.6 Italy Vaccine Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Vaccine Revenue by Type (2016-2026)
8.2 Asia-Pacific Vaccine Revenue by Application (2016-2026)
8.3 Asia-Pacific Vaccine Market Size by Region
8.3.1 Asia-Pacific Vaccine Revenue by Region (2016-2026)
8.3.2 China Vaccine Market Size and Forecast (2016-2026)
8.3.3 Japan Vaccine Market Size and Forecast (2016-2026)
8.3.4 South Korea Vaccine Market Size and Forecast (2016-2026)
8.3.5 India Vaccine Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Vaccine Market Size and Forecast (2016-2026)
8.3.7 Australia Vaccine Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Vaccine Revenue by Type (2016-2026)
9.2 South America Vaccine Revenue by Application (2016-2026)
9.3 South America Vaccine Market Size by Country
9.3.1 South America Vaccine Revenue by Country (2016-2026)
9.3.2 Brazil Vaccine Market Size and Forecast (2016-2026)
9.3.3 Argentina Vaccine Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Vaccine Revenue by Type (2016-2026)
10.2 Middle East & Africa Vaccine Revenue by Application (2016-2026)
10.3 Middle East & Africa Vaccine Market Size by Country
10.3.1 Middle East & Africa Vaccine Revenue by Country (2016-2026)
10.3.2 Turkey Vaccine Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Vaccine Market Size and Forecast (2016-2026)
10.3.4 UAE Vaccine Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Vaccine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Vaccine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Vaccine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Vaccine Revenue (USD Million) by Region (2016-2021)
Table 5. Global Vaccine Revenue Market Share by Region (2021-2026)
Table 6. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 7. AstraZeneca Major Business
Table 8. AstraZeneca Vaccine Product and Solutions
Table 9. AstraZeneca Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. BioNTech Corporate Information, Head Office, and Major Competitors
Table 11. BioNTech Major Business
Table 12. BioNTech Vaccine Product and Solutions
Table 13. BioNTech Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Boehringer-Ingelheim Corporate Information, Head Office, and Major Competitors
Table 15. Boehringer-Ingelheim Major Business
Table 16. Boehringer-Ingelheim Vaccine Product and Solutions
Table 17. Boehringer-Ingelheim Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. CCBIO Corporate Information, Head Office, and Major Competitors
Table 19. CCBIO Major Business
Table 20. CCBIO Vaccine Product and Solutions
Table 21. CCBIO Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. CSL Corporate Information, Head Office, and Major Competitors
Table 23. CSL Major Business
Table 24. CSL Vaccine Product and Solutions
Table 25. CSL Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. CureVac Corporate Information, Head Office, and Major Competitors
Table 27. CureVac Major Business
Table 28. CureVac Vaccine Product and Solutions
Table 29. CureVac Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Elanco Corporate Information, Head Office, and Major Competitors
Table 31. Elanco Major Business
Table 32. Elanco Vaccine Product and Solutions
Table 33. Elanco Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. GSK Corporate Information, Head Office, and Major Competitors
Table 35. GSK Major Business
Table 36. GSK Vaccine Product and Solutions
Table 37. GSK Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Hulan Bio Corporate Information, Head Office, and Major Competitors
Table 39. Hulan Bio Major Business
Table 40. Hulan Bio Vaccine Product and Solutions
Table 41. Hulan Bio Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Indian Immunologicals Corporate Information, Head Office, and Major Competitors
Table 43. Indian Immunologicals Major Business
Table 44. Indian Immunologicals Vaccine Product and Solutions
Table 45. Indian Immunologicals Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Merck Corporate Information, Head Office, and Major Competitors
Table 47. Merck Major Business
Table 48. Merck Vaccine Product and Solutions
Table 49. Merck Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Minhai Biotechnology Corporate Information, Head Office, and Major Competitors
Table 51. Minhai Biotechnology Major Business
Table 52. Minhai Biotechnology Vaccine Product and Solutions
Table 53. Minhai Biotechnology Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Mitsubishi Tanabe Pharma Corporate Information, Head Office, and Major Competitors
Table 55. Mitsubishi Tanabe Pharma Major Business
Table 56. Mitsubishi Tanabe Pharma Vaccine Product and Solutions
Table 57. Mitsubishi Tanabe Pharma Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Moderna Therapeutics Corporate Information, Head Office, and Major Competitors
Table 59. Moderna Therapeutics Major Business
Table 60. Moderna Therapeutics Vaccine Product and Solutions
Table 61. Moderna Therapeutics Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Mylan Corporate Information, Head Office, and Major Competitors
Table 63. Mylan Major Business
Table 64. Mylan Vaccine Product and Solutions
Table 65. Mylan Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Plumbline Life Sciences Corporate Information, Head Office, and Major Competitors
Table 67. Plumbline Life Sciences Major Business
Table 68. Plumbline Life Sciences Vaccine Product and Solutions
Table 69. Plumbline Life Sciences Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Sanofi Corporate Information, Head Office, and Major Competitors
Table 71. Sanofi Major Business
Table 72. Sanofi Vaccine Product and Solutions
Table 73. Sanofi Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Translate Bio Corporate Information, Head Office, and Major Competitors
Table 75. Translate Bio Major Business
Table 76. Translate Bio Vaccine Product and Solutions
Table 77. Translate Bio Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Walvax Biotechnology Corporate Information, Head Office, and Major Competitors
Table 79. Walvax Biotechnology Major Business
Table 80. Walvax Biotechnology Vaccine Product and Solutions
Table 81. Walvax Biotechnology Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Wuhan Institute of Biological Products Corporate Information, Head Office, and Major Competitors
Table 83. Wuhan Institute of Biological Products Major Business
Table 84. Wuhan Institute of Biological Products Vaccine Product and Solutions
Table 85. Wuhan Institute of Biological Products Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Zoties Corporate Information, Head Office, and Major Competitors
Table 87. Zoties Major Business
Table 88. Zoties Vaccine Product and Solutions
Table 89. Zoties Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Global Vaccine Revenue (USD Million) by Players (2019-2021)
Table 91. Global Vaccine Revenue Share by Players (2019-2021)
Table 92. Breakdown of Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 93. Vaccine Players Head Office, Products and Services Provided
Table 94. Vaccine Mergers & Acquisitions in the Past Five Years
Table 95. Vaccine New Entrants and Expansion Plans
Table 96. Global Vaccine Revenue (USD Million) by Type (2016-2021)
Table 97. Global Vaccine Revenue Share by Type (2016-2021)
Table 98. Global Vaccine Revenue Forecast by Type (2021-2026)
Table 99. Global Vaccine Revenue by Application (2016-2021)
Table 100. Global Vaccine Revenue Forecast by Application (2021-2026)
Table 101. North America Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 102. North America Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 103. North America Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 104. North America Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 105. North America Vaccine Revenue by Country (2016-2021) & (USD Million)
Table 106. North America Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 107. Europe Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 108. Europe Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 109. Europe Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 110. Europe Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 111. Europe Vaccine Revenue by Country (2016-2021) & (USD Million)
Table 112. Europe Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 113. Asia-Pacific Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 114. Asia-Pacific Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 115. Asia-Pacific Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 116. Asia-Pacific Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 117. Asia-Pacific Vaccine Revenue by Region (2016-2021) & (USD Million)
Table 118. Asia-Pacific Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 119. South America Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 120. South America Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 121. South America Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 122. South America Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 123. South America Vaccine Revenue by Country (2016-2021) & (USD Million)
Table 124. South America Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 125. Middle East & Africa Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 126. Middle East & Africa Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 127. Middle East & Africa Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 128. Middle East & Africa Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 129. Middle East & Africa Vaccine Revenue by Country (2016-2021) & (USD Million)
Table 130. Middle East & Africa Vaccine Revenue by Country (2021-2026) & (USD Million)

List of Figures
Figure 1. Vaccine Picture
Figure 2. Global Vaccine Revenue Market Share by Type in 2020
Figure 3. Varicella Vaccine
Figure 4. Influenza Vaccine
Figure 5. Polio Vaccine
Figure 6. Hepatitis A Vaccine
Figure 7. Rabies Vaccine
Figure 8. BCG Vaccine
Figure 9. Hepatitis B
Figure 10. Pertussis, Diphtheria, Tetanus
Figure 11. Pneumococcal
Figure 12. Others
Figure 13. Vaccine Revenue Market Share by Application in 2020
Figure 14. For Adult Picture
Figure 15. For Child Picture
Figure 16. Global Vaccine Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 17. Global Vaccine Revenue and Forecast (2016-2026) & (USD Million)
Figure 18. Global Vaccine Revenue Market Share by Region (2016-2026)
Figure 19. Global Vaccine Revenue Market Share by Region in 2020
Figure 20. North America Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Europe Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Asia-Pacific Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. South America Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Middle East and Africa Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Vaccine Market Drivers
Figure 26. Vaccine Market Restraints
Figure 27. Vaccine Market Trends
Figure 28. AstraZeneca Recent Developments and Future Plans
Figure 29. BioNTech Recent Developments and Future Plans
Figure 30. Boehringer-Ingelheim Recent Developments and Future Plans
Figure 31. CCBIO Recent Developments and Future Plans
Figure 32. CSL Recent Developments and Future Plans
Figure 33. CureVac Recent Developments and Future Plans
Figure 34. Elanco Recent Developments and Future Plans
Figure 35. GSK Recent Developments and Future Plans
Figure 36. Hulan Bio Recent Developments and Future Plans
Figure 37. Indian Immunologicals Recent Developments and Future Plans
Figure 38. Merck Recent Developments and Future Plans
Figure 39. Minhai Biotechnology Recent Developments and Future Plans
Figure 40. Mitsubishi Tanabe Pharma Recent Developments and Future Plans
Figure 41. Moderna Therapeutics Recent Developments and Future Plans
Figure 42. Mylan Recent Developments and Future Plans
Figure 43. Plumbline Life Sciences Recent Developments and Future Plans
Figure 44. Sanofi Recent Developments and Future Plans
Figure 45. Translate Bio Recent Developments and Future Plans
Figure 46. Walvax Biotechnology Recent Developments and Future Plans
Figure 47. Wuhan Institute of Biological Products Recent Developments and Future Plans
Figure 48. Zoties Recent Developments and Future Plans
Figure 49. Global Vaccine Revenue Share by Players in 2020
Figure 50. Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 51. Global Top 3 Players Vaccine Revenue Market Share in 2020
Figure 52. Global Top 10 Players Vaccine Revenue Market Share in 2020
Figure 53. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 54. Global Vaccine Revenue Share by Type in 2020
Figure 55. Global Vaccine Market Share Forecast by Type (2021-2026)
Figure 56. Global Vaccine Revenue Share by Application in 2020
Figure 57. Global Vaccine Market Share Forecast by Application (2021-2026)
Figure 58. North America Vaccine Sales Market Share by Type (2016-2026)
Figure 59. North America Vaccine Sales Market Share by Application (2016-2026)
Figure 60. North America Vaccine Revenue Market Share by Country (2016-2026)
Figure 61. United States Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Canada Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Mexico Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Europe Vaccine Sales Market Share by Type (2016-2026)
Figure 65. Europe Vaccine Sales Market Share by Application (2016-2026)
Figure 66. Europe Vaccine Revenue Market Share by Country (2016-2026)
Figure 67. Germany Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. France Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. United Kingdom Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Russia Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Italy Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Asia-Pacific Vaccine Sales Market Share by Type (2016-2026)
Figure 73. Asia-Pacific Vaccine Sales Market Share by Application (2016-2026)
Figure 74. Asia-Pacific Vaccine Revenue Market Share by Region (2016-2026)
Figure 75. China Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Japan Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Korea Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. India Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Southeast Asia Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Australia Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South America Vaccine Sales Market Share by Type (2016-2026)
Figure 82. South America Vaccine Sales Market Share by Application (2016-2026)
Figure 83. South America Vaccine Revenue Market Share by Country (2016-2026)
Figure 84. Brazil Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Argentina Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Middle East and Africa Vaccine Sales Market Share by Type (2016-2026)
Figure 87. Middle East and Africa Vaccine Sales Market Share by Application (2016-2026)
Figure 88. Middle East and Africa Vaccine Revenue Market Share by Country (2016-2026)
Figure 89. Turkey Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 90. Saudi Arabia Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 91. UAE Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 92. Methodology
Figure 93. Research Process and Data Source

Report Title: Global Vaccine Market 2021 by Company, Regions, Type and Application, Forecast to 2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW